Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aquestive Therapeutics, Inc. - Common Stock
(NQ:
AQST
)
3.080
-0.050 (-1.60%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aquestive Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
April 12, 2024
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 04, 2024
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%...
Via
Benzinga
A Preview Of Aquestive Therapeutics's Earnings
March 04, 2024
Via
Benzinga
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
April 04, 2024
U.S. stocks were higher, with the Dow Jones gaining over 150 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
April 01, 2024
Appoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of Directors
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
March 25, 2024
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Dow Surges 350 Points; Fed Holds Rates Steady
March 20, 2024
U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 20, 2024
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...
Via
Benzinga
Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher
March 20, 2024
U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% to 16,165.15. The S&P...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Fossil Fuels
Interest Rates
US Equities
A Stock Split Catalyst Looms for Chipotle (CMG) Stock on June 6
March 20, 2024
Chipotle stock is rising on Wednesday as investors in CMG shares react to the company seeking approval for a 50-for-one split.
Via
InvestorPlace
INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost
March 20, 2024
Intel stock is rising on Wednesday as investors in INTC shares react to the semiconductor company securing $8.5 billion in funding.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 20, 2024
Via
Benzinga
Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today?
March 20, 2024
Aquestive Therapeutics stock is falling on Wednesday after the company price a public offering for AQST shares this morning.
Via
InvestorPlace
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
March 20, 2024
Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 20, 2024
Pre-market stock movers are worth checking out as we dive into all of the biggest movements worth reading about on Wednesday morning!
Via
InvestorPlace
Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 20, 2024
U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
March 19, 2024
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 19, 2024
Via
Benzinga
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
March 19, 2024
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
March 15, 2024
Shares of Cardlytics, Inc. (NASDAQ: CDLX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter earnings.
Via
Benzinga
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 15, 2024
Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.
Via
Benzinga
Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting
March 14, 2024
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 08, 2024
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.
Via
Benzinga
AQST Stock Earnings: Aquestive Therapeutics Misses EPS, Beats Revenue for Q4 2023
March 05, 2024
AQST stock results show that Aquestive Therapeutics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
March 05, 2024
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 5, 2024
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via
Benzinga
Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET
February 21, 2024
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual Meeting
February 15, 2024
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
January 30, 2024
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Aquestive Therapeutics Doses First Patient in Phase 3 Pivotal Clinical Study Evaluating Pharmacokinetics and Pharmacodynamics of Anaphylm™ (epinephrine) Sublingual Film
December 05, 2023
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.